Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bronchicum Tropfen is a traditional herbal medicinal product used to improve symptoms of acute bronchitis and respiratory colds characterized by viscous mucus. It is a combination of liquid extracts from thyme herb (*Thymus vulgaris* or *Thymus zygis*) and primula root (*Primula veris* or *Primula elatior*). Thyme provides secretolytic, bronchospasmolytic, and antibacterial properties, primarily through its essential oil components like thymol and carvacrol, which interact with TRP channels and GABA receptors. Primula root contains saponins that act as expectorants by stimulating the gastric mucosa, which reflexively increases bronchial secretions. The product is marketed by MCM Klosterfrau and is frequently used as a standard-of-care comparator in clinical trials for herbal cough treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bronchicum Tropfen.